Huron Consulting Group (NASDAQ:HURN) Releases Quarterly Earnings Results, Beats Estimates By $0.38 EPS

Huron Consulting Group (NASDAQ:HURN) released its earnings results on Tuesday. The business services provider reported $1.90 earnings per share for the quarter, beating analysts’ consensus estimates of $1.52 by $0.38, Zacks reports. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The company had revenue of $399.31 million during the quarter, compared to analyst estimates of $380.62 million. Huron Consulting Group updated its FY 2025 guidance to 6.800-7.600 EPS.

Huron Consulting Group Stock Down 1.0 %

Shares of Huron Consulting Group stock traded down $1.43 during trading on Thursday, hitting $146.75. The company’s stock had a trading volume of 50,507 shares, compared to its average volume of 121,617. Huron Consulting Group has a 52 week low of $84.26 and a 52 week high of $153.77. The company has a market capitalization of $2.60 billion, a PE ratio of 31.90 and a beta of 0.59. The company has a fifty day simple moving average of $126.33 and a two-hundred day simple moving average of $117.59. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.61 and a current ratio of 1.61.

Analysts Set New Price Targets

HURN has been the subject of a number of analyst reports. Wedbush started coverage on Huron Consulting Group in a research note on Monday, February 3rd. They set an “outperform” rating for the company. Barrington Research upped their price target on shares of Huron Consulting Group from $142.00 to $167.00 and gave the company an “outperform” rating in a report on Thursday. Benchmark raised their price target on shares of Huron Consulting Group from $140.00 to $165.00 and gave the stock a “buy” rating in a report on Wednesday. Truist Financial reaffirmed a “buy” rating and set a $165.00 price objective (up from $140.00) on shares of Huron Consulting Group in a research note on Wednesday. Finally, William Blair reiterated an “outperform” rating on shares of Huron Consulting Group in a research report on Wednesday. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Huron Consulting Group presently has an average rating of “Buy” and a consensus target price of $151.75.

Insider Buying and Selling

In other Huron Consulting Group news, Director James H. Roth sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $123.70, for a total transaction of $247,400.00. Following the completion of the transaction, the director now owns 52,825 shares of the company’s stock, valued at approximately $6,534,452.50. This trade represents a 3.65 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director H Eugene Lockhart sold 1,042 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $122.81, for a total value of $127,968.02. Following the completion of the sale, the director now directly owns 26,756 shares in the company, valued at approximately $3,285,904.36. This represents a 3.75 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,584 shares of company stock valued at $1,067,539 over the last quarter. Corporate insiders own 2.02% of the company’s stock.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.